{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:50:42Z","timestamp":1761511842661,"version":"build-2065373602"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1016\/mjd.2003.550","type":"journal-article","created":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T21:04:03Z","timestamp":1059685443000},"page":"66-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"S","title":["Current systemic therapies for psoriasis: where are we now?"],"prefix":"10.1016","volume":"49","author":[{"given":"Paul S","family":"Yamauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Kormeili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rickie","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/mjd.2003.550_BIB1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.1987.tb05899.x","article-title":"Flow cytometric quantification of T6-positive cells in psoriatic epidermis after PUVA and methotrexate therapy","volume":"116","author":"Gommans","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000249475","article-title":"Study of psoriatic epidermal cell kinetics and cell death after oral methotrexate","volume":"171","author":"Newton","year":"1985","journal-title":"Dermatologica"},{"key":"10.1016\/mjd.2003.550_BIB3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000441-195102000-00009","article-title":"Therapeutic suppression of tissue reactivity","volume":"221","author":"Gubner","year":"1975","journal-title":"Am J Med Sci"},{"key":"10.1016\/mjd.2003.550_BIB4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archderm.1955.03730320035005","article-title":"Aminopterin for psoriasis","volume":"72","author":"Rees","year":"1955","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archderm.1958.01560080060010","article-title":"Treatment of psoriasis with folic acid antagonist","volume":"78","author":"Edmundson","year":"1958","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis","volume":"38","author":"Roenigk","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.1971.04000130035004","article-title":"Methotrexate for psoriasis. A new therapeutic schedule","volume":"103","author":"Weinstein","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0190-9622(93)70069-6","article-title":"Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis","volume":"28","author":"Duhra","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2008-1033731","article-title":"Reactivation of sunburn by methotrexate","volume":"200","author":"Lawrenz-Wolf","year":"1988","journal-title":"Klin Padiatr"},{"key":"10.1016\/mjd.2003.550_BIB10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archderm.1997.03890430083011","article-title":"Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis","volume":"133","author":"Paul","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB11","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1001\/jama.1988.03720240056034","article-title":"Pancytopenia following low-dose oral methotrexate therapy for psoriasis","volume":"259","author":"Shupack","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/mjd.2003.550_BIB12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0049-0172(85)90029-0","article-title":"Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis","volume":"15","author":"MacKinnon","year":"1985","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/mjd.2003.550_BIB13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9343(05)80060-9","article-title":"Methotrexate and histologic hepatic abnormalities","volume":"90","author":"Whiting-O\u2019Keefe","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/mjd.2003.550_BIB14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","article-title":"Complications following percutaneous liver biopsy","volume":"2","author":"Piccinino","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/mjd.2003.550_BIB15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2133.2001.03959.x","article-title":"The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis","volume":"14","author":"Zachariae","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2133.1996.d01-1036.x","article-title":"Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients","volume":"135","author":"Boffa","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2133.1988.tb03224.x","article-title":"Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis","volume":"119","author":"Risteli","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/mjd.2003.550_BIB19","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1001\/jama.1986.03380220076026","article-title":"Cyclosporine improves psoriasis in a double-blind study","volume":"256","author":"Ellis","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/mjd.2003.550_BIB20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/archderm.1987.01660260031006","article-title":"Cyclosporine in the treatment of psoriasis","volume":"123","author":"Wentzell","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0190-9622(87)70221-7","article-title":"Treatment of resistant severe psoriasis with systemic cyclosporine","volume":"17","author":"Picascia","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0190-9622(98)70325-1","article-title":"Cyclosporine consensus conference","volume":"39","author":"Lebwohl","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0190-9622(97)80219-8","article-title":"Cyclosporine as maintenance therapy in patients with severe psoriasis","volume":"36","author":"Shupack","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB24","first-page":"527","article-title":"Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study","volume":"136","author":"Berth-Jones","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB25","first-page":"32","article-title":"Low-dose cyclosporine effective in severe psoriasis","volume":"20","author":"Heule","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/mjd.2003.550_BIB26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(89)70154-7","article-title":"Effectiveness of cyclosporine treatment in severe psoriasis","volume":"21","author":"Finzi","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/mjd.2003.550_BIB28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1525-1470.2001.018003246.x","article-title":"Low dose cyclosporin A treatment in generalized pustular psoriasis","volume":"18","author":"Kilic","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB29","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.1993.01680310043006","article-title":"Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study","volume":"129","author":"Reitamo","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.0007-0963.2001.04529.x","article-title":"Etanercept for severe psoriasis and psoriatic arthritis","volume":"146","author":"Iyer","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2133.1999.02976.x","article-title":"Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis","volume":"141","author":"Clark","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB32","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(99)70363-4","article-title":"Systemic sequential therapy of psoriasis","volume":"41","author":"Koo","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0190-9622(96)90726-4","article-title":"Long-term low-dose cyclosporine therapy for severe psoriasis","volume":"35","author":"Lowe","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2133.1997.6101586.x","article-title":"Renal biopsy findings in long-term cyclosporin treatment of psoriasis","volume":"136","author":"Zachariae","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s004670050692","article-title":"Posttransplant lymphoproliferative disorder in pediatric renal transplantation","volume":"13","author":"Srivastava","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/mjd.2003.550_BIB36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"10.1016\/mjd.2003.550_BIB37","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/0190-9622(90)70357-N","article-title":"Immunity during cyclosporine therapy","volume":"23","author":"Valdimarsson","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2340\/00015555708990","article-title":"Combination therapy cyclosporin A\u2014PUVA in psoriasis","volume":"70","author":"Korstanje","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/mjd.2003.550_BIB39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/1523-1747.ep12472293","article-title":"Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol","volume":"100","author":"Larsen","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0190-9622(88)70163-2","article-title":"Systemic retinoid therapy for psoriasis","volume":"19","author":"Lowe","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB41","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0190-9622(99)70360-9","article-title":"Acitretin","volume":"41","author":"Ling","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB42","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0190-9622(99)70362-2","article-title":"Acitretin in combination with UVB or PUVA","volume":"41","author":"Lebwohl","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0190-9622(91)70089-K","article-title":"Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone","volume":"24","author":"Lowe","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.1989.tb01354.x","article-title":"Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone","volume":"120","author":"Iest","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1067\/mjd.2001.116347","article-title":"Consensus conference","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00128071-200102020-00008","article-title":"Calcipotriol ointment. A review of its use in the management of psoriasis","volume":"2","author":"Scott","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB47","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.136.12.1536","article-title":"Combination regimens of topical calcipotriene in chronic plaque psoriasis","volume":"136","author":"Ashcroft","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0733-8635(18)30632-6","article-title":"New retinoids for dermatologic diseases. Uses and toxicity","volume":"6","author":"Lowe","year":"1988","journal-title":"Dermatol Clin"},{"key":"10.1016\/mjd.2003.550_BIB49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2001.117047","article-title":"Treatment of psoriasis. Part 2. Systemic therapies","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/1523-1747.ep12610346","article-title":"Treatment of psoriasis with oral mycophenolic acid","volume":"65","author":"Jones","year":"1975","journal-title":"J Invest Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB51","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archderm.1977.01640070064007","article-title":"Mycophenolic acid in the treatment of psoriasis","volume":"113","author":"Marinari","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB52","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.1977.01640090051004","article-title":"Mycophenolic acid for psoriasis","volume":"113","author":"Lynch","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.1978.tb06537.x","article-title":"Mycophenolic acid in psoriasis","volume":"98","author":"Spatz","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0190-9622(79)80097-3","article-title":"Efficacy of mycophenolic acid for the treatment of psoriasis","volume":"1","author":"Gomez","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.2001.04088.x","article-title":"Mycophenolate mofetil as a systemic antipsoriatic agent","volume":"144","author":"Geilen","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB56","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2230.2001.00870.x","article-title":"Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis","volume":"26","author":"Ameen","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB57","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1067\/mjd.2000.104890","article-title":"Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil","volume":"42","author":"Grundmann-Kollmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0190-9622(91)70233-R","article-title":"Hydroxyurea therapy","volume":"25","author":"Boyd","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archderm.1970.04000080016003","article-title":"Hydroxyurea. A new treatment for psoriasis","volume":"102","author":"Leavell","year":"1970","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2133.1971.tb07185.x","article-title":"Hydroxyurea in the treatment of pustular psoriasis","volume":"85","author":"Stein","year":"1971","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2133.1971.tb07206.x","article-title":"Hydroxyurea","volume":"85","author":"Rosten","year":"1971","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archderm.1973.01620180017005","article-title":"Psoriasis with hydroxyurea. An 18-month study of 60 patients","volume":"107","author":"Moschella","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB63","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2133.1989.tb08198.x","article-title":"Hydroxyurea in the management of therapy resistant psoriasis","volume":"121","author":"Layton","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB64","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1365-4362.2001.01255.x","article-title":"Rediscovering hydroxyurea","volume":"40","author":"Kumar","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.0307-6938.2001.00947.x","article-title":"Mucocutaneous adverse effects of hydroxyurea","volume":"27","author":"Kumar","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0190-9622(94)70055-9","article-title":"6-Thioguanine treatment of psoriasis","volume":"30","author":"Zackheim","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2340\/00015555678588","article-title":"Thioguanine treatment in psoriasis","volume":"67","author":"Molin","year":"1987","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/mjd.2003.550_BIB68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archderm.135.4.433","article-title":"Pulse dosing of thioguanine in recalcitrant psoriasis","volume":"135","author":"Silvis","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1067\/mjd.2001.109296","article-title":"Thioguanine for refractory psoriasis","volume":"44","author":"Mason","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB70","first-page":"894","article-title":"Sulfasalazine therapy for psoriatic arthritis","volume":"22","author":"Gupta","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/mjd.2003.550_BIB71","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/rheumatology\/32.10.923","article-title":"Sulphasalazine in the management of psoriatic arthritis","volume":"32","author":"Fraser","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/mjd.2003.550_BIB72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0190-9622(89)70092-X","article-title":"Sulfasalazine","volume":"20","author":"Gupta","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-4615-4857-7_53","article-title":"Azathioprine in dermatological practice. An overview with special emphasis on its use in non-bullous inflammatory dermatoses","volume":"455","author":"Scerri","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/mjd.2003.550_BIB74","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-4362.1992.tb03548.x","article-title":"Azathioprine","volume":"31","author":"Hacker","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB75","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.1992.01680160065005","article-title":"Tacrolimus (FK 506)\u2014a new therapeutic agent for severe recalcitrant psoriasis","volume":"128","author":"Jegasothy","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB76","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1996.03890280081011","article-title":"Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study","volume":"132","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB77","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1517\/13543784.8.11.1859","article-title":"Pharmacological peroxisome proliferator-activated receptorgamma ligands","volume":"8","author":"Pershadsingh","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/mjd.2003.550_BIB78","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.136.5.609","article-title":"Troglitazone improves psoriasis and normalizes models of proliferative skin disease","volume":"136","author":"Ellis","year":"2000","journal-title":"Arch Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/mjd.2003.550_BIB79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0190-9622(96)80148-4","article-title":"Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994","volume":"34","author":"Menter","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB80","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.1997.tb03791.x","article-title":"The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis","volume":"137","author":"Muchenberger","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB81","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archderm.1990.01670280066012","article-title":"Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis","volume":"126","author":"Ruzicka","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB82","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0190-9622(91)70089-K","article-title":"Acitretin plus UVB therapy for psoriasis","volume":"24","author":"Lowe","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/mjd.2003.550_BIB83","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.1989.tb01354.x","article-title":"Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone","volume":"120","author":"Iest","year":"1989","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203011381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203011381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:26:45Z","timestamp":1759267605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962203011381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0190962203011381"],"URL":"https:\/\/doi.org\/10.1016\/mjd.2003.550","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2003,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current systemic therapies for psoriasis: where are we now?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/mjd.2003.550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}